Swiftmerge Acquisition Corp. (NASDAQ: IVCP) announced this afternoon that it has adjourned today’s meeting until Thursday, June 15, at 3:00 p.m.
The SPAC’s Chairman determined to postpone the meeting in order to allow for additional voting on the extension proposal which would extend Swiftmerge’s timeline from June 17, 2023 to March 15, 2024.
In connection with the adjournment, the company has also determined that it will allow shareholders who previously elected to redeem their Class A ordinary shares to reverse their requests by 5:00 p.m. ET on June 19.
Although Swiftmerge has not yet announced a definitive agreement, it signed a non-binding letter of intent (LOI) in April to combine with commercial-stage biotech company HDL. The parties’ press release did not include a proposed valuation for the deal, but the SPAC currently has about $228 million in trust. Swiftmerge is led by Chairman George Jones, CEO John “Sam” Bremmer, CFO Christopher J. Munyan, and COO and Secretary Aston Loch.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...